HKG Equity Snapshot
2315 Weekly Equity Report
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
What the company does
Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People's Republic of China, the United States, and internationally. It operates through five segments: Gene-Editing; Pharmacological Efficacy; Model Animals; Antibody Development; and Other. The company provides the customized gene editing services based on animals and cells to meet the needs of basic science research and drug development of the customers; provides the pre-clinical pharmacology service for drug efficacy and toxicity evaluation; engages in breeding and selling animal models for the external …
What the weekly tape is saying
2315 closed the latest completed week at 38.54 HKD. The 4-week return is -24.6% and the 12-week return is -25.6%. Trend Signal is inactive, Market Dynamics is -0.96. Setup signature: Risk-first tape with a 36/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 46.32 HKD
- Vs Trend Line
- -16.8%
- Fair Value
- 19.61 HKD
- Vs Fair Value
- 96.6%
- 52W High
- 70.15 HKD
- 52W Low
- 18.72 HKD
- Drawdown
- -45.1%
- Range Position
- 38.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 51
- 52W Active Breadth
- 98.1%
- Sector Scope
- HK Healthcare
- Sector Rank
- 223 of 257
- Sector Percentile
- 13.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 91 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 58 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.96
- 4W MD Change
- -94.9%
- Relative Strength
- 8.07
- 4W RS Change
- -81.7%
- Expectation
- Undecided
- Probability
- 45.00%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 10.5M
- 13W Average
- 6.6M
- 52W Average
- 4.8M
- Vs 13W
- 1.6x
- Vs 52W
- 2.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.3%
- 52W Volatility
- 9.2%
- Upside Weeks
- 24
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 8.8% / -5.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 19.8B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 38.54 HKD | -7.8% | 46.32 HKD | 19.61 HKD | -0.96 | 8.07 | 10.5M | Off |
| 5 Jun 2026 | 41.82 HKD | -15.4% | 46.12 HKD | 19.50 HKD | -0.99 | 17.11 | 10.5M | On |
| 29 May 2026 | 49.42 HKD | -0.9% | 45.66 HKD | 19.38 HKD | -1.05 | 38.93 | 4.6M | On |
| 22 May 2026 | 49.86 HKD | -2.4% | 44.95 HKD | 19.22 HKD | -0.87 | 40.14 | 5.7M | On |
| 15 May 2026 | 51.10 HKD | -0.7% | 44.05 HKD | 19.05 HKD | -0.49 | 44.17 | 4.2M | On |
| 8 May 2026 | 51.45 HKD | -1.8% | 43.10 HKD | 18.88 HKD | 0.01 | 45.78 | 3.7M | On |
| 1 May 2026 | 52.40 HKD | -12.7% | 42.23 HKD | 18.71 HKD | 0.58 | 55.19 | 8.3M | On |
| 24 Apr 2026 | 60.00 HKD | 2.5% | 41.39 HKD | 18.53 HKD | 1.11 | 80.06 | 5.7M | On |
| 17 Apr 2026 | 58.55 HKD | -2.4% | 40.35 HKD | 18.31 HKD | 1.38 | 79.26 | 7.4M | On |
| 10 Apr 2026 | 60.00 HKD | -5.5% | 39.31 HKD | 18.09 HKD | 1.43 | 90.54 | 5.1M | On |
| 3 Apr 2026 | 63.50 HKD | 8.6% | 38.08 HKD | 17.87 HKD | 1.45 | 113.74 | 6.5M | On |
| 27 Mar 2026 | 58.45 HKD | 12.8% | 36.80 HKD | 17.62 HKD | 1.47 | 104.51 | 9.0M | On |
| 20 Mar 2026 | 51.80 HKD | -4.5% | 35.60 HKD | 17.41 HKD | 1.46 | 84.17 | 4.1M | On |
| 13 Mar 2026 | 54.25 HKD | -0.7% | 34.71 HKD | 17.24 HKD | 1.52 | 96.15 | 5.6M | On |